secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0001093557-25-000278
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dexcom Q3 revenue $1.209B (+22% YoY); raises FY 2025 revenue guidance to $4.63-4.65B
--------------------------------------------------------------------------------

- GAAP EPS $0.70 vs $0.34 YoY; non-GAAP EPS $0.61 vs $0.45 YoY.
- U.S. revenue +21% YoY; international revenue +22% reported, +18% organic.
- GAAP operating margin 20.1% (480 bps improvement); non-GAAP operating margin 22.6%.
- Stelo surpassed $100M revenue in first 12 months; submitted Dexcom Smart Basal to FDA.
- Cash and marketable securities $3.32B; revolver undrawn.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355725000278/0001093557-25-000278-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355725000278/dxcm-20251030.htm
  HTML page:      https://secwatch.observer/filing/0001093557-25-000278

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer